KLB and Behcet disease: FGF15 administration to BD donors increased hepatic fibroblast growth factor receptor-4 and its co-receptor klotho-beta (FGFR4-KLB), reduced the cytochrome P450 7A1 (CYP7A1) enzyme and normalized BA levels.